432 related articles for article (PubMed ID: 8013162)
1. Lean body mass as a predictor of drug dosage. Implications for drug therapy.
Morgan DJ; Bray KM
Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162
[TBL] [Abstract][Full Text] [Related]
2. Relationships among liver and kidney volumes, lean body mass and drug clearance.
Nawaratne S; Brien JE; Seeman E; Fabiny R; Zalcberg J; Cosolo W; Angus P; Morgan DJ
Br J Clin Pharmacol; 1998 Nov; 46(5):447-52. PubMed ID: 9833597
[TBL] [Abstract][Full Text] [Related]
3. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
[TBL] [Abstract][Full Text] [Related]
4. Assessment of total body water and lean body mass from anthropometry, Watson formula, creatinine kinetics, and body electrical impedance compared with antipyrine kinetics in peritoneal dialysis patients.
de Fijter WM; de Fijter CW; Oe PL; ter Wee PM; Donker AJ
Nephrol Dial Transplant; 1997 Jan; 12(1):151-6. PubMed ID: 9027791
[TBL] [Abstract][Full Text] [Related]
5. Lean Body Mass and Total Body Weight Versus Body Surface Area as a Determinant of Docetaxel Pharmacokinetics and Toxicity.
Hoge RHL; Detert Oude Weme SEH; Vervenne WL; van Berlo-van de Laar IRF; van Herpen CML; Roorda L; Mathôt RAA; Jacobs MS; van Erp NP; Jansman FGA
Ther Drug Monit; 2022 Dec; 44(6):755-761. PubMed ID: 36006609
[TBL] [Abstract][Full Text] [Related]
6. Effects of obesity on pharmacokinetics implications for drug therapy.
Cheymol G
Clin Pharmacokinet; 2000 Sep; 39(3):215-31. PubMed ID: 11020136
[TBL] [Abstract][Full Text] [Related]
7. Effect of obesity on the pharmacokinetics of drugs in humans.
Hanley MJ; Abernethy DR; Greenblatt DJ
Clin Pharmacokinet; 2010; 49(2):71-87. PubMed ID: 20067334
[TBL] [Abstract][Full Text] [Related]
8. The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007.
McLeay SC; Morrish GA; Kirkpatrick CM; Green B
Clin Pharmacokinet; 2012 May; 51(5):319-30. PubMed ID: 22439649
[TBL] [Abstract][Full Text] [Related]
9. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
Ghobadi C; Johnson TN; Aarabi M; Almond LM; Allabi AC; Rowland-Yeo K; Jamei M; Rostami-Hodjegan A
Clin Pharmacokinet; 2011 Dec; 50(12):809-22. PubMed ID: 22087867
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of drugs in obesity. An update.
Cheymol G
Clin Pharmacokinet; 1993 Aug; 25(2):103-14. PubMed ID: 8403734
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the Relationship Between Lean Liver Volume and Fat-Free Mass.
Sinha J; Duffull SB; Green B; Al-Sallami HS
Clin Pharmacokinet; 2020 Apr; 59(4):475-483. PubMed ID: 31583612
[TBL] [Abstract][Full Text] [Related]
12. Lean body mass is better than body surface area in correcting GFR.
Si H; Lei Z; Li S; Liu J; Geng J; Chen S
Clin Nucl Med; 2013 May; 38(5):e210-5. PubMed ID: 22996236
[TBL] [Abstract][Full Text] [Related]
13. Sources of variation in estimates of lean body mass by creatinine kinetics and by methods based on body water or body mass index in patients on continuous peritoneal dialysis.
Tzamaloukas AH; Murata GH; Piraino B; Raj DS; VanderJagt DJ; Bernardini J; Servilla KS; Sun Y; Glew RH; Oreopoulos DG
J Ren Nutr; 2010 Mar; 20(2):91-100. PubMed ID: 19853476
[TBL] [Abstract][Full Text] [Related]
14. Interdependence of lean body mass and total body water, but not quality of life measures, during low dose GH replacement in GH-deficient adults.
Mukherjee A; Adams JE; Smethurst L; Shalet SM
Eur J Endocrinol; 2005 Nov; 153(5):661-8. PubMed ID: 16260424
[TBL] [Abstract][Full Text] [Related]
15. Remifentanil pharmacokinetics in obese versus lean patients.
Egan TD; Huizinga B; Gupta SK; Jaarsma RL; Sperry RJ; Yee JB; Muir KT
Anesthesiology; 1998 Sep; 89(3):562-73. PubMed ID: 9743391
[TBL] [Abstract][Full Text] [Related]
16. Drug Distribution in Obesity and following Bariatric Surgery: A Literature Review.
Macgregor AM; Boggs L
Obes Surg; 1996 Feb; 6(1):17-27. PubMed ID: 10731246
[TBL] [Abstract][Full Text] [Related]
17. Four-site skinfold anthropometry (FSA) versus body impedance analysis (BIA) in assessing nutritional status of patients on maintenance hemodialysis: which method is to be preferred in routine patient care?
Oe B; de Fijter CW; Oe PL; Stevens P; de Vries PM
Clin Nephrol; 1998 Mar; 49(3):180-5. PubMed ID: 9543600
[TBL] [Abstract][Full Text] [Related]
18. Contribution of genetic and environmental factors to variation in body compartments--a twin study in adults.
Hanisch D; Dittmar M; Höhler T; Alt KW
Anthropol Anz; 2004 Mar; 62(1):51-60. PubMed ID: 15109035
[TBL] [Abstract][Full Text] [Related]
19. Higher extracellular fluid volume in women is concealed by scaling to body surface area.
Peters AM; Seshadri N; Neilly MD; Perry L; Hooker CA; Howard B; Sobnack R; Irwin A; Dave S; Snelling H; Gruning T; Patel NH; Shabo G; Williams N; Barnfield MC; Lawson RS
Scand J Clin Lab Invest; 2013 Oct; 73(7):546-52. PubMed ID: 24047330
[TBL] [Abstract][Full Text] [Related]
20. Changes in lean body mass in obese children during a weight reduction program: effect on short term and long term outcome.
Schwingshandl J; Borkenstein M
Int J Obes Relat Metab Disord; 1995 Oct; 19(10):752-5. PubMed ID: 8589770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
